3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
6
Phase 3
3
Phase NA
1
Phase 1/2
1
Phase 1
1
Status
Unknown
11
Completed
9
Terminated
5
Recruiting
4
Suspended
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
NET
1
Gastrointestinal
1
Endocrine
1
Conditions
Breast Neoplasms
267
Prostatic Neoplasms
144
Neoplasms
139
Lung Neoplasms
84
Colorectal Neoplasms
61
Motor Activity
55
Uterine Cervical Neoplasms
44
Carcinoma, Non-Small-Cell Lung
43
Pancreatic Neoplasms
35
Head and Neck Neoplasms
34
Colonic Neoplasms
34
Ovarian Neoplasms
33
Brain Neoplasms
32
Carcinoma, Hepatocellular
27
Neoplasm Metastasis
26
Rectal Neoplasms
24
Stomach Neoplasms
22
Melanoma
19
Hematologic Neoplasms
19
Endometrial Neoplasms
19
Liver Neoplasms
18
Anxiety Disorders
18
Kidney Neoplasms
16
Glioma
16
Squamous Cell Carcinoma of Head and Neck
15
Papillomavirus Infections
15
Fatigue
15
Esophageal Neoplasms
15
Obesity
14
Multiple Myeloma
14
Interventions
Poly(ADP-ribose) Polymerase Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Active not recruiting
×
Gastrointestinal Stromal Tumors
×
Clear all
NCT04584008
2024-10-15
VISIONARY
Peking University
Phase NA
Active not recruiting
600 enrolled